MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Stiff person syndrome: Case series

    E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)

    Objective: To report and discuss three cases of Stiff Person Syndrome (SPS) with distinguished clinical features. Background: SPS is a rare disorder characterised by progressive…
  • 2016 International Congress

    Is physiotherapy an effective for treatment of Parkinson’s disease?!

    R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)

    Objective: Aim of investigation was to evaluate the effectiveness of physiotherapy intervention compared with no intervention in patients with PD. Background: In spite of various…
  • 2016 International Congress

    Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study

    R. Miguel, M. Mendonça, R. Barbosa, F. Ladeira, T. Lampreia, J. Vale, P. Bugalho (Lisbon, Portugal)

    Objective: To assess the efficacy and side-effects of TBZ in Huntington disease (HD), vascular chorea, tics, dystonia, oromandibular dyskinesia and other tardive syndromes (TS). Background:…
  • 2016 International Congress

    Diverse effects of alpha-synuclein fibrils on various neuron cell lines, using different buffers

    F. Aliakbari, D. Morshedi, A.A. Shabani, H. Mohammad Beigi, A. Tayaranian Marvian, P. Shariati, S.A. Shojaosadati, A.A. Saboury (Semnan, Islamic Republic of Iran)

    Objective: To investigate the neurotoxic properties of alpha-synuclein (α-Syn) aggregation in different buffers including PBS, SBF and Tris on altered cell lines, SHSY5Y, SK-N-MC and…
  • 2016 International Congress

    Diagnostic value of a new coronal examination plane in transcranial nigral sonography and of additional M-mode tremor frequency determination for the differentiation of idiopathic Parkinson’s disease and essential tremor

    L. Tönges, R. Daniel, D. Woitalla, S. Muhlack, R. Gold, C. Krogias (Bochum, Germany)

    Objective: To (1) evaluate a new coronal examination plane in comparison to the established axial examination plane for detection of nigral hyperechogenicity and (2) to…
  • 2016 International Congress

    Real-life data on the use of levodopa carbidopa intestinal gel in Parkinson’s disease

    J.T. Butler, D. Isaacs, C. Tolleson, R. Pierce, T. Davis (Nashville, TN, USA)

    Objective: To report our institution's initial clinical experience with initiation and management of levodopa carbidopa intestinal gel (LCIG) formulation Duopa®. Background: Carbidopa/levodopa intestinal gel (LCIG)…
  • 2016 International Congress

    Inhibition of glucosylceramide synthase reduces pathology and improves cognition in synucleinopathy murine models

    L. Shihabuddin, C. Viel, J. Clarke, H. Park, J.C. Dodge, J. Marshall, B. Wang, S.H. Cheng, S.P. Sardi (Framingham, MA, USA)

    Objective: We investigated the merits of glucosylceramide synthase (GCS) inhibition as a potential treatment for synucleinopathies. Background: Mutations in GBA, the gene encoding glucocerebrosidase, are…
  • 2016 International Congress

    Correlation between Parkinson’s disease and malignant tumors

    E. Binaghi, M.M. Mascia, P. Solla, M. Meloni, R. Farris, D. Ciaccio, G. Orofino, F. Marrosu, A. Cannas (Cagliari, Italy)

    Objective: We have carried out the research among the group of Sardinian patients with PD, led by our Ambulatory of Movement Disorders, to evaluate the…
  • 2016 International Congress

    Real world conversion of levodopa to a novel extended release levodopa preparation: Determining predictors and dose ratios

    W. Ondo, P. Coss, M. Christie (Houston, TX, USA)

    Objective: To determine predictors of response and conversion ratios for a novel extended release levodopa preparation. Background: A new extended release levodopa preparation, Rytary®, has…
  • 2016 International Congress

    Virtual-reality balance training with Nintendo-Wii games improves dynamic balance in Parkinson’s disease patients

    G.H. Lee (Cheon-An, Korea)

    Objective: This study was to investigate the effectiveness of a 8-week virtual reality exercise program designed around the Nintendo Wii (Wii), in improving balance among…
  • « Previous Page
  • 1
  • …
  • 1465
  • 1466
  • 1467
  • 1468
  • 1469
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley